Ledger.Open graph →
SEC Form D · filed November 24, 2023

Octave Bioscience Inc

Offering
$7.0M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
MENLO PARK, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

George Scangos · MENLO PARK, CADirectorAndrea Jackson · MENLO PARK, CADirectorBrook Byers · MENLO PARK, CADirectorThomas Hawes · MENLO PARK, CADirectorMichael Pellini · MENLO PARK, CADirectorA. Grant Heidrich Iii · MENLO PARK, CADirectorWilliam Hagstrom · MENLO PARK, CAExec · DirectorMelinda Thomas · MENLO PARK, CAExecKenton C. Leo · Lone Tree, COExec · DirectorAngela J. Brau · Provo, UTDirectorClifford Pollard · Oakdale, CADirectorDerrin J. Hill · Provo, UTDirectorDana Emberton · Greenville, SCDirectorJonathan Landsverk · Greenville, SCDirectorJonathan D. Herpy · Wilmington, DEDirectorChristopher Mclaughlin · Chicago, ILExecBobby Marhamat · San Francisco, CAExec · DirectorJack Abraham · San Francisco, CAExecTuan Ho · San Francisco, CADirectorLeo Polovets · San Francisco, CADirectorChad Byers · San Francisco, CADirectorBrandon Tseng · San Diego, CADirectorDaniel Gwak · San Diego, CADirectorPeter Levine · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗